High-grade serous carcinoma (HGSC)

August 30, 2019September 4, 2019

Research into Tumor Suppressor P53 in Ovarian Cancer Receives $1.8M NIH Grant

News

A research team at the David Geffen School of Medicine at UCLA received a $1.8 million, five-year grant from the National Institutes of Health (NIH) to develop new therapeutic and ... Read more

June 7, 2019

Immune Checkpoint Molecules Have Prognostic Value in Ovarian Cancer, Study Reports

News

The immune checkpoint molecules PD-L1 and TIM-3 have prognostic value in people with ovarian cancer who have not yet received chemotherapy. But while low levels of TIM-3 were linked to ... Read more

February 28, 2018February 28, 2018

Potential Therapeutic Target Identified to Fight Metastasis in Ovarian Cancer

News

High levels of CXCR4, a receptor for signaling molecules that drive cell movement, allow ovarian cancer cells to grow faster and spread to other parts of the body, a study ... Read more

March 10, 2017March 10, 2017

Surface Protein, CD151, May Be Marker of Aggressive Serous Ovarian Cancer

News

A protein called CD151 is highly expressed on the surface of high-grade serous carcinoma (HGSC) cells, the most common and lethal subtype of ovarian cancers, recent research found. Expression of this ... Read more